findmyKOL
Clinical trialNCT00615667CompletedPhase 3Interventional

Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)

SponsorSun Yat-sen UniversityEnrollment61Kidney DiseasesNephrotic SyndromeTacrolimus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jian Chen, MD

    Department of Nephrology, Fuzhou Military General Hospital

    Principal Investigator
    clinicaltrials.gov ↗
  • Jin li Zhang, MD

    Department of nephrology, People's Hospital of Yunnan Province

    Principal Investigator
    clinicaltrials.gov ↗
  • Junzhou Fu, MD

    Department of Nephrology,1st People's Hospital of Guangzhou

    Principal Investigator
    clinicaltrials.gov ↗
  • Ping Fu, MD

    Department of Nephrology, West China Hospital of Sichuan University

    Principal Investigator
    clinicaltrials.gov ↗
  • Tanqi Lou, MD

    Department of Nephrology, 3rd Affiliated Hospital of Sun Yet-Sen University

    Principal Investigator
    clinicaltrials.gov ↗
  • Wei Shi, MD

    Department of Nephrology, People's Hospital Guangdong Provincial

    Principal Investigator
    clinicaltrials.gov ↗
  • Xueqing Yu, MD

    Department of Nephrology, 1st Affiliated Hospital, Sun Yat-Sen University

    Principal Investigator
    clinicaltrials.gov ↗
  • Yaozhong Kong, MD

    Department of Nephrology, 1st People's Hospital of Foshan

    Principal Investigator
    clinicaltrials.gov ↗
  • Yunhua Liao, MD

    Department of Nephrology, 1st Affiliated Hospital of Guangxi Medical University

    Principal Investigator
    clinicaltrials.gov ↗
  • Zhengrong Liu, MD

    Department of Nephrology, Nanfang Hospital of Southern Medical University

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2006
Primary completion
30 Sept 2008
Completion
30 Sept 2008
Last update posted
20 Apr 2016
Registered enrollment
61
Registry id
NCT00615667
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.